-
1
-
-
69249117423
-
New drugs for exacerbations of chronic obstructive pulmonary disease
-
Hansel TT, Barnes PJ. New drugs for exacerbations of chronic obstructive pulmonary disease. Lancet. 2009;374(9691):744-755.
-
(2009)
Lancet
, vol.374
, Issue.9691
, pp. 744-755
-
-
Hansel, T.T.1
Barnes, P.J.2
-
2
-
-
27744556967
-
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
-
DOI 10.1136/thx.2005.040527
-
Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925-931. (Pubitemid 41598207)
-
(2005)
Thorax
, vol.60
, Issue.11
, pp. 925-931
-
-
Soler-Cataluna, J.J.1
Martinez-Garcia, M.A.2
Roman, S.P.3
Salcedo, E.4
Navarro, M.5
Ochando, R.6
-
3
-
-
80955169343
-
General practitioner's adherence to the COPD GOLD guidelines: Baseline data of the Swiss COPD Cohort Study
-
Jochmann A, Neubauer F, Miedinger D, Schafroth S, Tamm M, Leuppi JD. General practitioner's adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort Study. Swiss Med Wkly. 2010;140:w13053.
-
(2010)
Swiss Med Wkly
, vol.140
-
-
Jochmann, A.1
Neubauer, F.2
Miedinger, D.3
Schafroth, S.4
Tamm, M.5
Leuppi, J.D.6
-
4
-
-
84860767710
-
Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort
-
Jochmann A, Scherr A, Jochmann DC, et al. Impact of adherence to the GOLD guidelines on symptom prevalence, lung function decline and exacerbation rate in the Swiss COPD cohort. Swiss Med Wkly. 2012;142:w13567.
-
(2012)
Swiss Med Wkly
, vol.142
-
-
Jochmann, A.1
Scherr, A.2
Jochmann, D.C.3
-
5
-
-
4544382557
-
Management of severe COPD
-
Wouters EF. Management of severe COPD. Lancet. 2004;364(9437):883-895.
-
(2004)
Lancet
, vol.364
, Issue.9437
, pp. 883-895
-
-
Wouters, E.F.1
-
6
-
-
84925226849
-
Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
-
Walters JAE, Wang W, Morley C, Soltani A, Wood-Baker R. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011;(10):CD006897.
-
(2011)
Cochrane Database Syst Rev
, Issue.10
-
-
Walters, J.A.E.1
Wang, W.2
Morley, C.3
Soltani, A.4
Wood-Baker, R.5
-
7
-
-
84868337504
-
Global strategy for the diagnosis, management and prevention of COPD
-
Accessed April 18, 2013
-
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. http://www.goldcopd.org/ guidelines/guidelines-resources.html. Accessed April 18, 2013.
-
Global Initiative for Chronic Obstructive Lung Disease
-
-
-
8
-
-
0029739943
-
Controlled trial of oral prednisone in outpatients with acute COPD exacerbation
-
Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ. Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med. 1996;154(2 pt 1):407-412. (Pubitemid 26269111)
-
(1996)
American Journal of Respiratory and Critical Care Medicine
, vol.154
, Issue.2
, pp. 407-412
-
-
Thompson, W.H.1
Nielson, C.P.2
Carvalho, P.3
Charan, N.B.4
Crowley, J.J.5
-
9
-
-
0033533144
-
Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: A prospective randomised controlled trial
-
DOI 10.1016/S0140-6736(98)11326-0
-
Davies L, Angus RM, Calverley PM. Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease: a prospective randomised controlled trial. Lancet. 1999;354(9177):456- 460. (Pubitemid 29368923)
-
(1999)
Lancet
, vol.354
, Issue.9177
, pp. 456-460
-
-
Davies, L.1
Angus, R.M.2
Calverley, P.M.A.3
-
10
-
-
0033600275
-
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease
-
DOI 10.1056/NEJM199906243402502
-
Niewoehner DE, Erbland ML, Deupree RH, et al Department of Veterans Affairs Cooperative Study Group. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1999;340(25):1941-1947. (Pubitemid 29288269)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.25
, pp. 1941-1947
-
-
Niewoehner, D.E.1
Erbland, M.L.2
Deupree, R.H.3
Collins, D.4
Gross, N.J.5
Light, R.W.6
Anderson, P.7
Morgan, N.A.8
-
11
-
-
0037832413
-
Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease
-
DOI 10.1056/NEJMoa023161
-
Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med. 2003;348(26):2618-2625. (Pubitemid 36741589)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.26
, pp. 2618-2625
-
-
Aaron, S.D.1
Vandemheen, K.L.2
Hebert, P.3
Dales, R.4
Stiell, I.G.5
Ahuja, J.6
Dickinson, G.7
Brison, R.8
Rowe, B.H.9
Dreyer, J.10
Yetisir, E.11
Cass, D.12
Wells, G.13
-
12
-
-
77953626306
-
Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease
-
Lindenauer PK, Pekow PS, Lahti MC, Lee Y, Benjamin EM, Rothberg MB. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease. JAMA. 2010;303(23):2359-2367.
-
(2010)
JAMA
, vol.303
, Issue.23
, pp. 2359-2367
-
-
Lindenauer, P.K.1
Pekow, P.S.2
Lahti, M.C.3
Lee, Y.4
Benjamin, E.M.5
Rothberg, M.B.6
-
13
-
-
0043234165
-
Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD
-
DOI 10.1378/chest.124.2.459
-
Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest. 2003;124(2):459-467. (Pubitemid 37000120)
-
(2003)
Chest
, vol.124
, Issue.2
, pp. 459-467
-
-
Groenewegen, K.H.1
Schols, A.M.W.J.2
Wouters, E.F.M.3
-
14
-
-
79952196700
-
Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease - The "REDUCE" trial
-
Schuetz P, Leuppi JD, Tamm M, et al. Short versus conventional term glucocorticoid therapy in acute exacerbation of chronic obstructive pulmonary disease - the "REDUCE" trial. Swiss Med Wkly. 2010;140:w13109.
-
(2010)
Swiss Med Wkly
, vol.140
-
-
Schuetz, P.1
Leuppi, J.D.2
Tamm, M.3
-
15
-
-
0023164742
-
Antiobiotic therapy in exacerbations of chronic obstructive pulmonary disease
-
Anthonisen NR, Manfreda J, Warren CP, Hershfield ES, Harding GK, Nelson NA. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196-204. (Pubitemid 17009877)
-
(1987)
Annals of Internal Medicine
, vol.106
, Issue.2
, pp. 196-204
-
-
Anthonisen, N.R.1
Manfreda, J.2
Warren, C.P.W.3
-
16
-
-
1842552109
-
Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper
-
Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23(6):932-946. (Pubitemid 38807371)
-
(2004)
European Respiratory Journal
, vol.23
, Issue.6
, pp. 932-946
-
-
Celli, B.R.1
MacNee, W.2
Agusti, A.3
Anzueto, A.4
Berg, B.5
Buist, A.S.6
Calverley, P.M.A.7
Chavannes, N.8
Dillard, T.9
Fahy, B.10
Fein, A.11
Heffner, J.12
Lareau, S.13
Meek, P.14
Martinez, F.15
McNicholas, W.16
Muris, J.17
Austegard, E.18
Pauwels, R.19
Rennard, S.20
Rossi, A.21
Siafakas, N.22
Tiep, B.23
Vestbo, J.24
Wouters, E.25
ZuWallack, R.26
more..
-
17
-
-
84871484789
-
Reporting of noninferiority and equivalence randomized trials: Extension of the CONSORT 2010 statement
-
CONSORT Group
-
Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG; CONSORT Group. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA. 2012;308(24):2594-2604.
-
(2012)
JAMA
, vol.308
, Issue.24
, pp. 2594-2604
-
-
Piaggio, G.1
Elbourne, D.R.2
Pocock, S.J.3
Evans, S.J.W.4
Altman, D.G.5
-
18
-
-
0035035768
-
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary
-
Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256-1276. (Pubitemid 32378468)
-
(2001)
American Journal of Respiratory and Critical Care Medicine
, vol.163
, Issue.5
, pp. 1256-1276
-
-
Pauwels, R.A.1
Buist, A.S.2
Calverley, P.M.A.3
Jenkins, C.R.4
Hurd, S.S.5
-
19
-
-
0034064973
-
Toward a consensus definition for COPD exacerbations
-
Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117(5)(suppl 2):398S-401S. (Pubitemid 30314474)
-
(2000)
Chest
, vol.117
, Issue.5 SUPPL. 2
-
-
Rodriguez-Roisin, R.1
-
20
-
-
0008485492
-
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
-
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581-586. (Pubitemid 29296676)
-
(1999)
Thorax
, vol.54
, Issue.7
, pp. 581-586
-
-
Bestall, J.C.1
Paul, E.A.2
Garrod, R.3
Garnham, R.4
Jones, P.W.5
Wedzicha, J.A.6
-
21
-
-
0037062141
-
Azithromycin for acute bronchitis: A randomised, double-blind, controlled trial
-
DOI 10.1016/S0140-6736(02)08597-5
-
Evans AT, Husain S, Durairaj L, Sadowski LS, Charles-Damte M, Wang Y. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet. 2002;359(9318):1648-1654. (Pubitemid 34518524)
-
(2002)
Lancet
, vol.359
, Issue.9318
, pp. 1648-1654
-
-
Evans, A.T.1
Husain, S.2
Durairaj, L.3
Sadowski, L.S.4
Charles-Damte, M.5
Wang, Y.6
-
22
-
-
1342265610
-
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial
-
DOI 10.1016/S0140-6736(04)15591-8
-
Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363(9409):600-607. (Pubitemid 38264177)
-
(2004)
Lancet
, vol.363
, Issue.9409
, pp. 600-607
-
-
Christ-Crain, M.1
Jaccard-Stolz, D.2
Bingisser, R.3
Gencay, M.M.4
Huber, P.R.5
Tamm, M.6
Muller, B.7
-
23
-
-
0035089716
-
Systemic glucocorticoids in severe exacerbations of COPD
-
DOI 10.1378/chest.119.3.726
-
Sayiner A, Aytemur ZA, Cirit M, Unsal I. Systemic glucocorticoids in severe exacerbations of COPD. Chest. 2001;119(3):726-730. (Pubitemid 32197640)
-
(2001)
Chest
, vol.119
, Issue.3
, pp. 726-730
-
-
Sayiner, A.1
Aytemur, Z.A.2
Cirit, M.3
Unsal, I.4
-
24
-
-
33846311358
-
Antibiotic treatment of exacerbations of COPD: A randomized, controlled trial comparing procalcitonin-guidance with standard therapy
-
DOI 10.1378/chest.06-1500
-
Stolz D, Christ-Crain M, Bingisser R, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest. 2007;131(1):9-19. (Pubitemid 46122969)
-
(2007)
Chest
, vol.131
, Issue.1
, pp. 9-19
-
-
Stolz, D.1
Christ-Grain, M.2
Bingisser, R.3
Leuppi, J.4
Miedinger, D.5
Muller, C.6
Huber, P.7
Muller, B.8
Tamm, M.9
-
25
-
-
78649745984
-
Prevalence of airflow obstruction in smokers and never-smokers in Switzerland
-
Bridevaux PO, Probst-Hensch NM, Schindler C, et al. Prevalence of airflow obstruction in smokers and never-smokers in Switzerland. Eur Respir J. 2010;36(6):1259-1269.
-
(2010)
Eur Respir J
, vol.36
, Issue.6
, pp. 1259-1269
-
-
Bridevaux, P.O.1
Probst-Hensch, N.M.2
Schindler, C.3
|